What is QGEN's market cap?

$10.50B, based on the Nov 5 close of $50.86.

Does QIAGEN pay a dividend?

Yes. The latest regular dividend was $0.35 per share (ex-date Jul 7), an annualised yield of 0.69%.

How much of QGEN is sold short?

7.2M shares, 3.5% of float, as of Oct 15, 2026.

NYSE · QGEN

QIAGEN N.V. (QGEN)

$50.86+0.06%

Close Nov 5, 2026 · split-adjusted

Nov 5, 2026$50.73▲ 14.87% in range

Nov 4, 2025Low $32.63 · High $55.66Nov 5, 2026

What changed · written from our data

As of Nov 5, 2026

QIAGEN closed at $50.86 on Nov 5, up 0.06%, 8.6% below its 52-week closing high. Volume of 4.6M shares was 0.78× its 20-day average (below normal).

Split-adjusted performance: +13.6% over one month, +51.8% over six months, +15.2% over one year.

Short interest was 7.2M shares at the Oct 15 settlement, down 6.2% from the prior report (3.5% of float, 3.3 days to cover).

Market cap$10.50B206.5M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield0.69%$0.35 last paid

52-week range32.63 – 55.66−8.6% from high

Volume4.6M0.78× 20-day avg

Volatility · 60d32.0%Annualised

Short % of float3.5%3.3 days to cover

Net cash-$555.5MCash $1.10B

Next earnings—Not scheduled

Split-adjusted performance

1W +1.0%1M +13.6%3M +20.2%6M +51.8%YTD +13.1%1Y +15.2%3Y +28.1%5Y −11.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short7.2M−6.2% vs prior

Days to cover3.3Settled Oct 15

% of float3.5%

Short vol. 10d31.5%of daily volume

News about QIAGEN

All news →

Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key MetricsZacks Investment Research · 1d ago▲ Positive Do Options Traders Know Something About Qiagen Stock We Don't?Zacks Investment Research · 5d agoNeutral Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research · Oct 28, 2026▲ Positive Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc. · Oct 22, 2026▼ Negative QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the FirmGlobeNewswire Inc. · May 15, 2026▼ Negative

Quick answers

What does QIAGEN do?: Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between life sciences and molecular diagnostics applications.
What is QGEN's market cap?: $10.50B, based on the Nov 5 close of $50.86.
Does QIAGEN pay a dividend?: Yes. The latest regular dividend was $0.35 per share (ex-date Jul 7), an annualised yield of 0.69%.
How much of QGEN is sold short?: 7.2M shares, 3.5% of float, as of Oct 15, 2026.

About QIAGEN

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between life sciences and molecular diagnostics applications. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

5,500 employeesListed Jun 28, 1996qiagen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology